Innovation

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

Pandemic leads to broader use of monoclonal antibodies

Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

Rosenbloom appointed to National Library of Medicine’s Biomedical Informatics, Library and Data Sciences Review Committee

Trent Rosenbloom, MD, MPH, professor and vice chair of Faculty Affairs in the Department of Biomedical Informatics, has been appointed to the National Library of Medicine’s (NLM) Biomedical Informatics, Library and Data Sciences (BILDS) Review Committee.